6,6',6''-(2,4,6-Trimethylbenzene-1,3,5-triyl)tris(2-naphthoic acid), 97%, 1g

Disopyramide>98.0%(HPLC)(T)1g

Analytical balance HR series Models with internal calibration, 0.0001 g, 152 g, HR-150AZ (W)

2-(4-methoxyphenyl)-1-(piperazin-1-yl)ethan-1-one, 95.0%, 1g

N-(3,5-bis((Triisopropylsilyl)oxy)phenyl)-3-hydroxy-2-nitrobenzamide, 95%, 250mg

4-Hydroxy-7-methoxycoumarin>98.0%(GC)(T)5g

3-(acetylamino)-1-methyl-1H-pyrazole-5-carboxylic acid, 95.0%, 250mg

(S)-3-((tert-Butoxycarbonyl)amino)-4-(3,4-dichlorophenyl)butanoic acid, 95.0%, 250mg

(4-Chlorophenyl)(piperazin-1-yl)methanone, 95.0%, 25g

1,4-Dioxaspiro[4.5]decan-8-ylmethanamine, 95.0%, 250mg

tert-Butyl 4-(4-cyanobenzoylamino)piperidine-1-carboxylate, 95.0%, 1g

2,5-Dioxopyrrolidin-1-yl 14-oxo-18-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10-trioxa-13-azaoctadecanoate, 95%, 100mg

5-Bromo-1-ethoxy-2-fluoro-3-methylbenzene, 98%, 5g